Experimental Medicine - Developing biomarkers in early discovery to bridge preclinical and clinical development - Drug Discovery World (DDW)
Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma | Scientific Reports
Sborník abstrakt z neurochirurgického kurzu 2012
Správa o činnosti organizácie SAV za rok 2020
Tulathromycin treatment does not affect bacterial... | proLékaře.cz
Physical determinants of vault performance and the... | proLékaře.cz
Characterization of testis-specific serine/threoni... | proLékaře.cz
Frontiers | Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review
Characterization of testis-specific serine/threoni... | proLékaře.cz
JCDD | Free Full-Text | A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis—The Rise of IGF-BP2 and GDF-15
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers | Nature Medicine
Identification of glomerular and podocyte-specific... | proLékaře.cz
Výroční zpráva
Identification of glomerular and podocyte-specific... | proLékaře.cz
Pre-market development times for biologic versus small-molecule drugs | Nature Biotechnology
Eupolyphaga sinensis Walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling | Scientific Reports
Cancers | Free Full-Text | Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
Characterization of testis-specific serine/threoni... | proLékaře.cz
REVIEWs CoSMIC INHERITANCE RULES: IMPLICATIoNS FoR HEALTH CARE AND SCIENCE . . . . . . . . . . . . . . . . . . . . . . . . . . .
Characterization of testis-specific serine/threoni... | proLékaře.cz
REVIEWs CoSMIC INHERITANCE RULES: IMPLICATIoNS FoR HEALTH CARE AND SCIENCE . . . . . . . . . . . . . . . . . . . . . . . . . . .
Správa o činnosti organizácie SAV za rok 2020
Organizační schéma ÚKBLD Pracovníci
Protein BIOMARKER Strategies - Drug Discovery World (DDW)
Physical determinants of vault performance and the... | proLékaře.cz
